ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
6 hedge funds and large institutions have $7.22K invested in ZyVersa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$6.16K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$1.04K |
| 3 |
3
Morgan Stanley
New York
|
$2 |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$19 |
Top Sellers
| 1 |
ACM
1
ADAR1 Capital Management
Austin,
Texas
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $6.16K | +$4.48K | +1,867 | +267% |
|
|
2
UBS Group
Zurich,
Switzerland
| $1.04K | +$1.04K | +433 | New |
|
|
3
Bank of America
Charlotte,
North Carolina
| $19 | +$2 | +1 | +14% |
|
4
JPMorgan Chase & Co
New York
| $2 | – | – | – |
|
|
5
Morgan Stanley
New York
| $2 | +$2 | +1 | New |
|
|
ACM
6
ADAR1 Capital Management
Austin,
Texas
| – | -$36.1K | -9,598 | Closed |
|